Clearside Biomedical Statistics

Total Valuation

CLSD has a market cap or net worth of $59.14 million. The enterprise value is $99.57 million.

Market Cap	59.14M
Enterprise Value	99.57M

Important Dates

The last earnings date was Wednesday, May 14, 2025, after market close.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

CLSD has 77.71 million shares outstanding. The number of shares has increased by 18.12% in one year.

Current Share Class	77.71M
Shares Outstanding	77.71M
Shares Change (YoY)	+18.12%
Shares Change (QoQ)	+1.41%
Owned by Insiders (%)	13.26%
Owned by Institutions (%)	14.26%
Float	67.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.28
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	26.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.19

Current Ratio	3.19
Quick Ratio	3.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.58

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-54.08%
Return on Invested Capital (ROIC)	-102.14%
Return on Capital Employed (ROCE)	-176.57%
Revenue Per Employee	$117,625
Profits Per Employee	-$962,875
Employee Count	32
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

In the past 12 months, CLSD has paid $715,000 in taxes.

Income Tax	715,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.63% in the last 52 weeks. The beta is 2.11, so CLSD's price volatility has been higher than the market average.

Beta (5Y)	2.11
52-Week Price Change	-43.63%
50-Day Moving Average	0.87
200-Day Moving Average	1.00
Relative Strength Index (RSI)	34.28
Average Volume (20 Days)	161,626

Short Selling Information

The latest short interest is 222,436, so 0.29% of the outstanding shares have been sold short.

Short Interest	222,436
Short Previous Month	249,709
Short % of Shares Out	0.29%
Short % of Float	0.33%
Short Ratio (days to cover)	1.87

Income Statement

In the last 12 months, CLSD had revenue of $3.76 million and -$30.81 million in losses. Loss per share was -$0.41.

Revenue	3.76M
Gross Profit	3.37M
Operating Income	-25.88M
Pretax Income	-34.97M
Net Income	-30.81M
EBITDA	-25.60M
EBIT	-25.88M
Loss Per Share	-$0.41

Full Income Statement

Balance Sheet

The company has $13.63 million in cash and $54.06 million in debt, giving a net cash position of -$40.43 million or -$0.52 per share.

Cash & Cash Equivalents	13.63M
Total Debt	54.06M
Net Cash	-40.43M
Net Cash Per Share	-$0.52
Equity (Book Value)	-45.91M
Book Value Per Share	-0.59
Working Capital	10.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$22.68 million and capital expenditures -$929,000, giving a free cash flow of -$23.61 million.

Operating Cash Flow	-22.68M
Capital Expenditures	-929,000
Free Cash Flow	-23.61M
FCF Per Share	-$0.30

Full Cash Flow Statement

Margins

Gross Margin	89.45%
Operating Margin	-687.51%
Pretax Margin	-799.60%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLSD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.12%
Shareholder Yield	-18.12%
Earnings Yield	-52.10%
FCF Yield	-39.92%

Analyst Forecast

The average price target for CLSD is $4.80, which is 530.75% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.80
Price Target Difference	530.75%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	144.67%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CLSD has an Altman Z-Score of -28.59 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-28.59
Piotroski F-Score	1